COMMUNIQUÉS West-GlobeNewswire
-
Expansion Updates That Fuel Wildflower’s Growth Strategy
05/06/2018 - 15:30 -
Konica Minolta Introduces AeroRemote Insights: Interactive Analytic and Business Intelligence Reporting for Radiology
05/06/2018 - 15:07 -
The Newly Elected Supervisory Council of Olainfarm Will Continue Development of the Company
05/06/2018 - 15:02 -
Obalon Announces Upcoming Conference Presentation
05/06/2018 - 15:01 -
Imprivata Enables Healthcare’s Shift to Mobile with Fast, Secure Access to Clinical Mobile Devices and Applications
05/06/2018 - 15:00 -
ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
05/06/2018 - 15:00 -
Wildflower Brands Inc.: Financing Closed
05/06/2018 - 15:00 -
Ceapro Announces Results of 2018 Shareholders’ Meeting
05/06/2018 - 15:00 -
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
05/06/2018 - 14:58 -
CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference
05/06/2018 - 14:57 -
Syneos Health to Present Actionable Commercial Insights Designed for Biopharmaceutical Companies at BIO International Convention
05/06/2018 - 14:55 -
PolarityTE Announces Pricing of Public Follow-on Offering of Common Stock
05/06/2018 - 14:49 -
ICC Labs Announces Its First Presale Agreement of CBD/THC Extracts and CBD/THC Oils for Distribution in Colombia
05/06/2018 - 14:34 -
Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT®.TB Test
05/06/2018 - 14:30 -
Radius to Host Investor Day on June 8, 2018
05/06/2018 - 14:30 -
OpGen’s Acuitas® AMR Gene Panel u5.47 Data to be Presented at ASM Microbe 2018
05/06/2018 - 14:30 -
Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive Disease Week 2018
05/06/2018 - 14:30 -
TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer
05/06/2018 - 14:30 -
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
05/06/2018 - 14:30
Pages